Teriflunomide Tablet, Film Coated
Product Images NDC 0378-0627

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 0378-0627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teriflunomide Structural Formula (Image 01)

Chemical structure of Teriflunomide, showing its molecular arrangement including a trifluoromethyl group attached to a benzene ring, and other functional groups typical to this active ingredient.*

FDA Label Image

Figure 1: Kaplan-meier Plot Of Time To Disability Progression Sustained For 12 Weeks (study 1) (Image 02)

A Kaplan-Meier curve graph illustrating the percentage of disability progression sustained for 12 weeks over a period of 108 weeks. The graph compares three groups: placebo, 7 mg teriflunomide tablets, and 14 mg teriflunomide tablets, with the 14 mg group showing the lowest progression percentage. Below the x-axis, a table displays the number of patients at risk over time for each group.*

FDA Label Image

Figure 2: Kaplan-meier Plot Of Time To Disability Progression Sustained For 12 Weeks (study 2) (Image 03)

A line chart comparing the percentage of disability progression sustained over 12 weeks across 108 weeks for placebo, 7 mg Teriflunomide tablets, and 14 mg Teriflunomide tablets. The graph includes the number of patients at risk at various time points for each group. The data illustrate treatment effect differences over time between the groups.*

FDA Label Image

Teriflunomide Tablets 7 mg (Image 04)

Teriflunomide 7 mg film-coated tablets packaging label from Mylan Pharmaceuticals Inc. The label indicates a 30-tablet count with usage instructions noting a single tablet dose daily. It includes storage information and a pharmacist instruction to dispense the accompanying Medication Guide with the product.*

FDA Label Image

Teriflunomide Tablets 14 mg (Image 05)

Teriflunomide 14 mg film-coated tablets label by Mylan Pharmaceuticals Inc. The label includes the strength 14 mg, dosage form as tablets, pharmacy dispensing instructions, storage conditions, and contains 30 tablets per container. It also shows the NDC number 0378-0628-93 and barcodes for scanning. The label includes warnings to keep medication out of reach of children and storage instructions at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.